Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Total Current Liabilities (2020 - 2025)

Cellebrite DI has reported Total Current Liabilities over the past 6 years, most recently at $369.7 million for Q4 2025.

  • Quarterly results put Total Current Liabilities at $369.7 million for Q4 2025, up 25.09% from a year ago — trailing twelve months through Dec 2025 was $369.7 million (up 25.09% YoY), and the annual figure for FY2025 was $369.7 million, up 25.09%.
  • Total Current Liabilities for Q4 2025 was $369.7 million at Cellebrite DI, up from $295.5 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for CLBT hit a ceiling of $369.7 million in Q4 2025 and a floor of $186.6 million in Q4 2021.
  • Median Total Current Liabilities over the past 5 years was $253.8 million (2023), compared with a mean of $262.7 million.
  • Biggest five-year swings in Total Current Liabilities: grew 11.36% in 2022 and later grew 25.09% in 2025.
  • Cellebrite DI's Total Current Liabilities stood at $186.6 million in 2021, then increased by 11.36% to $207.8 million in 2022, then increased by 22.16% to $253.8 million in 2023, then increased by 16.42% to $295.5 million in 2024, then increased by 25.09% to $369.7 million in 2025.
  • The last three reported values for Total Current Liabilities were $369.7 million (Q4 2025), $295.5 million (Q4 2024), and $253.8 million (Q4 2023) per Business Quant data.